Stem cells as the root of pancreatic ductal adenocarcinoma

被引:37
|
作者
Balic, Anamaria [1 ]
Dorado, Jorge [1 ]
Alonso-Gomez, Mercedes [1 ]
Heeschen, Christopher [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Stem Cell & Canc Grp, Clin Res Programme, Madrid 28029, Spain
关键词
Pancreatic cancer; Cancer stem cells; Tumor-initiating cells; Inflammation; Targeted therapy; CIRCULATING TUMOR-CELLS; HEDGEHOG PATHWAY; CANCER-CELLS; SIGNALING PATHWAYS; DOWN-REGULATION; MOUSE MODEL; C-MET; CXCR4; GEMCITABINE; EXPRESSION;
D O I
10.1016/j.yexcr.2011.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence suggests that stem cells play a crucial role not only in the generation and maintenance of different tissues, but also in the development and progression of malignancies. For the many solid cancers, it has now been shown that they harbor a distinct subpopulation of cancer cells that bear stem cell features and therefore, these cells are termed cancer stem cells (CSC) or tumor-propagating cells. CSC are exclusively tumorigenic and essential drivers for tumor progression and metastasis. Moreover, it has been shown that pancreatic ductal adenocarcinoma does not only contain one homogeneous population of CSC rather than diverse subpopulations that may have evolved during tumor progression. One of these populations is called migrating CSC and can be characterized by CXCR4 co-expression. Only these cells are capable of evading the primary tumor and traveling to distant sites such as the liver as the preferred site of metastatic spread. Clinically even more important, however, is the observation that CSC are highly resistant to chemo- and radiotherapy resulting in their relative enrichment during treatment and rapid relapse of disease. Many laboratories are now working on the further in-depth characterization of these cells, which may eventually allow for the identification of their Achilles heal and lead to novel treatment modalities for fighting this deadly disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:691 / 704
页数:14
相关论文
共 50 条
  • [41] MicroRNAs in pancreatic ductal adenocarcinoma
    Park, Jong Y.
    Helm, James
    Coppola, Domenico
    Kim, Donghwa
    Malafa, Mokenge
    Kim, Seung Joon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (07) : 817 - 827
  • [42] Hypoxia and pancreatic ductal adenocarcinoma
    Yamasaki, Akio
    Yanai, Kosuke
    Onishi, Hideya
    CANCER LETTERS, 2020, 484 : 9 - 15
  • [43] RESTRAINING PANCREATIC DUCTAL ADENOCARCINOMA PROGRESSION WITH CHOP DEPLETION IN PANCREATIC EPITHELIAL CELLS
    Muranaka, Hayato
    Yong, Jing
    Waldron, Richard T.
    Aquino, Albert-Fred
    Jang, Insook
    Kaufman, Randal J.
    Pandol, Stephen J.
    Lugea, Aurelia
    GASTROENTEROLOGY, 2024, 166 (05) : S241 - S241
  • [44] Macrophages and pancreatic ductal adenocarcinoma
    Habtezion, Aida
    Edderkaoui, Mouad
    Pandol, Stephen J.
    CANCER LETTERS, 2016, 381 (01) : 211 - 216
  • [45] Staging of pancreatic ductal adenocarcinoma
    Sauvanet, A
    Zins, M
    JOURNAL DE CHIRURGIE, 1998, 135 (01): : 10 - 16
  • [46] Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
    He-Li Gao
    Wen-Quan Wang
    Xian-Jun Yu
    Liang Liu
    Experimental Hematology & Oncology, 9
  • [47] Immunotherapy for pancreatic ductal adenocarcinoma
    Carpenter, Eileen
    Nelson, Sarah
    Bednar, Filip
    Cho, Clifford
    Nathan, Hari
    Sahai, Vaibhav
    di Magliano, Marina Pasca
    Frankel, Timothy L.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 751 - 759
  • [48] Biomarkers in pancreatic ductal adenocarcinoma
    Gallego, J.
    Lopez, C.
    Pazo-Cid, R.
    Lopez-Rios, F.
    Carrato, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12): : 1430 - 1437
  • [49] Desmoplasia of Pancreatic Ductal Adenocarcinoma
    Pandol, Stephen
    Edderkaoui, Mouad
    Gukovsky, Ilya
    Lugea, Aurelia
    Gukovskaya, Anna
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (11) : S44 - S47
  • [50] Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
    Gao, He-Li
    Wang, Wen-Quan
    Yu, Xian-Jun
    Liu, Liang
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)